Revenue volatility and a combined ratio of 100.7% in 2026Q3, versus 83.4% in 2026Q2, indicate underwriting margins that are thin and inconsistent.
Accelerant Holdings (ARX) annual income statement — 5-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 |
|---|
| Revenue | 967.6M | 879.5M | 597.7M | 329.7M | 213.1M | 103.2M |
| Revenue Growth % | 17.26% | 47.15% | 81.29% | 54.72% | 106.49% | - |
| Medical Costs & Claims | 337.7M | 284.3M | 248.7M | 130.2M | 134.5M | 39.7M |
| Medical Cost Ratio % | 34.9% | 32.33% | 41.61% | 39.49% | 63.12% | 38.47% |
| Gross Profit | 629.9M | 595.2M | 349M | 199.5M | 78.6M | 63.5M |
| Gross Margin % | 65.1% | 67.67% | 58.39% | 60.51% | 36.88% | 61.53% |
| Gross Profit Growth % | - | 70.54% | 74.94% | 153.82% | 23.78% | - |
| Operating Expenses | 572.3M | 1.92B | 317M | 243.4M | 162.9M | 83.5M |
| OpEx / Revenue % | 59.15% | 217.98% | 53.04% | 73.82% | 76.44% | 80.91% |
| Depreciation & Amortization | 41.1M | 35.2M | 26.6M | 14.5M | 5.8M | 1.6M |
| Combined Ratio % | 94.05% | 250.3% | 94.65% | 113.32% | 139.56% | 119.38% |
| Operating Income | 57.5M | -1.32B | 32M | -43.9M | -84.3M | -20M |
| Operating Margin % | 5.94% | -150.3% | 5.35% | -13.32% | -39.56% | -19.38% |
| Operating Income Growth % | - | -4230.94% | 172.89% | 47.92% | -321.5% | - |
| EBITDA | 98.6M | -1.29B | 58.6M | -29.4M | -78.5M | -18.4M |
| EBITDA Margin % | 10.19% | -146.3% | 9.8% | -8.92% | -36.84% | -17.83% |
| Interest Expense | 49.8M | 69M | 32.4M | 15.1M | 4.2M | 2.9M |
| Non-Operating Income | -36.2M | -69M | -32.4M | -15.1M | -4.2M | -2.9M |
| Pretax Income | 85.6M | -1.32B | 32M | -43.9M | -84.3M | -20M |
| Pretax Margin % | 8.85% | -150.3% | 5.35% | -13.32% | -39.56% | -19.38% |
| Income Tax | 18M | 23.3M | 9.1M | 20.2M | 11.3M | 4.3M |
| Effective Tax Rate % | 21.03% | -1.76% | 28.44% | -46.01% | -13.4% | -21.5% |
| Net Income | 60.6M | -1.35B | 27.2M | -48.8M | -91.7M | -21.5M |
| Net Margin % | 6.26% | -153.96% | 4.55% | -14.8% | -43.03% | -20.83% |
| Net Income Growth % | 104.55% | -5078.31% | 155.74% | 46.78% | -326.51% | - |
| EPS (Diluted) | 0.28 | -7.49 | 0.13 | -0.23 | -0.55 | -0.10 |
| EPS Growth % | 103.92% | -5861.54% | 156.52% | 58.18% | -454.44% | - |
| EPS (Basic) | - | -7.49 | 0.17 | -0.30 | -0.55 | -0.13 |
| Diluted Shares Outstanding | 217.17M | 190.26M | 216.67M | 216.67M | 165.6M | 216.67M |
Quick answers to the most common questions about buying ARX stock.
For fiscal year 2025, Accelerant Holdings (ARX) reported total revenue of $879.5M. This represents a 752.2% increase compared to $103.2M in 2021.
Accelerant Holdings (ARX) reported a net loss of $1.35B for the fiscal year ending 2025.
Accelerant Holdings (ARX) reported an operating income of $-1321.9M, resulting in an operating profit margin of -150.3%. This margin reflects the operational efficiency of the business before interest and taxes.
Accelerant Holdings (ARX) generated $595.2M in gross profit for the year, representing a gross profit margin of 67.7%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Persistent underwriting and EPS volatility
Metrics are mathematically derived from official filings.
Premium Momentum Diverges From Earnings
As reported in quarterly figures, ARX's revenue fell 25.7% year over year to $208.5M in 2026Q3 after a 74.8% sequential jump in Q2, indicating that top-line growth has become highly uneven across recent periods and is difficult to extrapolate with confidence.
The swing from strong sequential expansion to a sharp year-over-year contraction suggests that premium recognition timing or the mix of exchange versus underwriting volume may be driving much of the reported variability. Management's disclosed exchange written premium growth of 27% points to continued platform adoption, but the gap between that premium momentum and negative quarterly earnings suggests gross volume alone does not confirm economic profitability. Investors should monitor whether revenue stabilizes at a higher base or continues to oscillate.
Combined Ratio Hovering Near Breakeven
Based on reported figures, ARX's combined ratio ranged from 83.4% in Q2 2026 to 101.1% in Q4 2025, with the most recent quarter at 100.7%, implying underwriting results are only marginally profitable at best and dependent on non-underwriting income.
A combined ratio sitting around 100% indicates that underwriting roughly breaks even, leaving the company reliant on fee income and any investment returns to generate profit. The loss ratio moved from 29.8% to 42.4% across recent quarters, which suggests claims experience is volatile and may be sensitive to the risk mix ceded by MGA partners. Continued negative operating income despite these ratios indicates that fixed platform and compliance costs are absorbing whatever underwriting margin exists.
Earnings Volatility Warrants Reserve Scrutiny
As reported in financial statements, ARX posted an EPS of -6.99 in 2025Q3 driven by a roughly $1.4B net loss, a magnitude that appears inconsistent with the otherwise modest quarterly loss ratio of 26.2% and warrants further investigation into reserve development.
A loss of this scale relative to a $280.7M revenue quarter is difficult to reconcile with a 26.2% loss ratio, which may indicate a one-time reserve charge, impairment, or non-operating adjustment rather than ordinary underwriting deterioration. Because the supplied data does not disclose the composition of this charge, no conclusion about reserve adequacy can be drawn with confidence. Analysts should review prior-year development disclosures to determine whether earlier periods were flattered by releases.
Investment Income Contribution Undisclosed
Based on the supplied quarterly data, ARX shows no investment income or investment yield line, so the contribution of portfolio returns to total earnings cannot be assessed from the available figures and is treated as data unavailable.
Given the reported cash balance of roughly $1.79B, investment income could be a material earnings component, but the absence of this data means its role is unavailable rather than demonstrably small. Without yield information, it is not possible to judge whether investment returns are offsetting operating losses. Investors should seek the investment income disclosure directly from filings before drawing conclusions about earnings quality.
Operating Deleverage Driven by Fixed Costs
As reported in financial statements, ARX's operating margin of -150.3% against a 67.7% gross margin on $879.5M of trailing revenue suggests overhead is consuming more than the entire gross profit pool.
A gap of this size between gross and operating margin implies that platform development, personnel, and regulatory costs are large relative to the current revenue base. Until fee and premium volume scale faster than these largely fixed expenses, operating leverage is likely to remain negative. The trajectory of operating expenses relative to revenue is therefore the key variable to monitor.
Underwriting Breakeven Masks Adverse Selection Risk
Based on reported figures, ARX's combined ratio near 100% and 42.4% loss ratio in Q1 2026 may understate risk if MGA-sourced business is adversely selected, a possibility the supplied data cannot confirm or rule out.
The strongest challenge to reported results is that the exchange may attract MGA programs that have struggled to place risk elsewhere, which could push loss ratios higher as these books mature beyond the current short observation window. If that dynamic is present, the favorable 83.4% combined ratio seen in Q2 2026 may reflect timing rather than durable underwriting quality. Investors should weigh reserve development and loss emergence against the reported growth before accepting current ratios as representative.